Invest 101
VC Fund
Çankaya, Turkey
Invest 101 is a venture capital fund that provides capital investments, mentoring, and access to networks for startups. It is established in partnership with the Turkish Development Fund and ODTÜ TEKNOKENT.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Invest 101 invests in
SoftwareRoboticsBiopharmaIndustrialAgriculture
Stages Invest 101 invests in
SeedFunding RoundVenture - Series Unknown
Countries Invest 101 invests in
United StatesFranceTurkey
Investment Focus
Industry
- Software 2 (20%)
- Robotics 1 (10%)
- Biopharma 1 (10%)
- Industrial 1 (10%)
- Agriculture 1 (10%)
Stage
- Seed 2 (20%)
- Funding Round 1 (10%)
- Venture - Series Unknown 1 (10%)
Country
- United States 2 (20%)
- France 1 (10%)
- Turkey 1 (10%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Meddenovo Drug Design
|
Meddenovo is at the forefront of AI-driven drug discovery, pioneering a specialized technology platform designed specifically for cyclic peptides. Our innovative approach leverages a unique blend of AI technologies and molecular modeling to significantly enhance the efficiency and success rates of drug development processes. Cyclic peptidesrepresent a groundbreaking class of compounds in pharmaceutical research. These molecules combine the best attributes of small molecules and large biologics, offering exceptional binding affinities, stability, and specificity. At Meddenovo, we are leaders in harnessing the potential of cyclic peptides, developing tailored solutions that push the boundaries of traditional drug discovery. Beyond small organic molecules, our expertise extends to peptide-based medicines and metal chelators, giving us a competitive edge in novel drug research and development. We excel in creating unique chemical spaces tailored to your needs and provide custom computational solutions for predicting drug resistance, elucidating biochemical reaction mechanisms, and conducting metal affinity analysis. At Meddenovo, we are dedicated to precision and reliability in drug discovery. Our approach reduces failure rates and improves outcomes, accelerating the journey from research to market. Our mission is to empower scientists worldwide with advanced, user-friendly AI tools, democratizing access to cutting-edge drug discovery technologies. | Seed / Jan 01, 2025 | |
Rnv.ai
|
RNV Analytics provides AI and ML driven solutions for inventory allocation problem of retail companies. With algorithmics recommendation, their customers decide which product should be located in which sales points both online and offline. | $1.1M / Seed / Nov 28, 2024 | |
Cellsway
|
Cellsway is a liquid biopsy company that was created to provide quick cancer CTC detection methods. The business's technology, which is minimally invasive and uses a straightforward blood sample for cancer monitoring, enables healthcare professionals to heal their patients and enhance their quality of life. focuses on the development ofmicrofluidics and lab-on-a-chip technologies for biomedical purposes. | $390K / Seed / Aug 22, 2024 | |
FenixPyre
|
FenixPyre is a file-centric security solution that keeps files transparently and persistently encrypted at rest, in transit, and in use. Once, protected, organizations can control access to the files based on user role, geolocation, IP range, and other attributes. Organizations do not need to change any of the workflows to consume the files, butthey will have full ownership – with the ability to revoke access even when the files are exfiltrated. As a result, data cannot be stolen even with valid credentials or insiders. FenixPyre is based on zero-trust principles enforced at the data layer. FenixPyre can be used to protect any file type, including not only documents, but also proprietary AI models, CAD files, and source code. | $3.1M / Venture - Series Unknown / Aug 15, 2024 | |
robolaunch
|
robolaunch is released by multi-domain engineers who develop better integrated, interoperable and scalable cloud robotics platform. robolaunch is a RaaS(Robotics as a Service) product that offers users to design, develop, simulate, train, deploy and orchestrate own ROS/ROS2 based robots at planet scale!Main robolaunch features are, - RobotMarketplace with single click - Collaboration through platform IDE and VDI - Multi-Tenancy for Organizational Management - Teleoperation and Fleet Management - Hardware Acceleration(GPU, FPGA, CPU) - Central Orchestration Fleet lifecycle management - Edge Orchestration Robot lifecycle management(LCM) - Declerative and API driven operations - Multi-Cloud, Multi-Region and Multi-Robot orchestration - Connectivity Management (5G, VPN, L2/L3) - On-premise and Public Cloud Management - FCAPS for each level of platform | $1.5M / Seed / Jun 13, 2024 | |
Idenfit
|
Cloud based human resources software and workforce management. Idenfit online human resources and workforce management software brings a holistic approach to human resources functions and it helps you to review and manage hr processes all in one place. Idenfit is cloud based HR software for SMEs as well as international companies that have outgrownspreadsheets. We automate many of the most tedious HR functions and create time for you to do meaningful work. Whether you’re an employee trying to request time-off or an HR manager looking forward to grow and develop your company’s workforce, Idenfit is your all-in-one HR management solution. | $1.5M / Seed / Feb 21, 2024 | |
DAtAnchor
|
DAtAnchor develops a novel crypto-technology that anchors the data consumption within the network boundaries, serving as a backstop against inevitable breaches. It provides a secure gateway to access the files in the cloud and the database, with the added features of revocability and physical access control, enabling efficient and automated datagovernance.DAtAnchor is a result of a multi-year research activity, developed at Ohio State University. The development team currently has 6 members, 4 of which are full-time. We have seed level funding for >1M and an advisory board with members at the senior vice president level in Fortune 500 companies. | $6.3M / Venture - Series Unknown / Jan 17, 2024 | |
Gesund
|
MLOps company currently focused on streamlining clinical validation of AI solutions | $1M / Seed / Aug 25, 2023 | |
Clay Token Game Studio
|
Clay Token Game Studio is a game development company that produces cutting-edge games for gamers. | $250K / Seed / Jun 01, 2023 | |
DefensX
|
DefensX makes sure the users are safe working anywhere on any network or device including desktops, laptops, and, iOS & Android. DefensX bundles Remote Browser Isolation, Zero Trust File Protection, and Zero Trust Credential Exposure functionalities for secure remote work. | $2.5M / Pre-Seed / Apr 05, 2023 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
SaaS Investors
99,274 investors
Software Investors
50,021 investors
Health Care Investors
43,014 investors
Climate Investors
40,325 investors
Hardware Investors
40,144 investors
Biotech Investors
21,775 investors
Agriculture (agtech) Investors
10,346 investors
SaaS VC Funds
61,208 investors
Software VC Funds
31,919 investors
FAQ
What does Invest 101 invest in?
Invest 101 invests primarily in Software, Robotics and Biopharma startups, most often at Seed and Funding Round stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Invest 101 last invest?
The most recent investment recorded for Invest 101 closed in Jan 2025. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
